Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...
TG Therapeutics shares made new 52-week highs this week, helped in part by new Briumvi data presentations at ECTRIMS. Find ...
The FDA has approved FluMist nasal spray as the first at-home flu vaccine. People aged 18 and older can now self-administer ...
The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...
The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a ...
Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, making it the ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...